Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Boehringer Ingelheim is a global and diverse group of companies and people all driven by the desire to serve mankind by improving human and animal health. We are proud of our long history of philanthropy and social responsibility. Family-owned since our founding in 1885, we feel a special responsibility towards our communities and respect for our resources. As we continue to develop breakthrough therapies and healthcare solutions in areas of unmet medical need, access is core to our business and values. We aspire to offer sustainable delivery of More Health to humans, animals and communities around the world by building unique initiatives, both commercial and philanthropic, based on partnerships and local empowerment.